Reduced anti-PRP antibody response to Hib immunisation in preterm (<32 weeks) UK infants who received inactivated polio (eIPV)

Vaccine

Volumn 25, Issue 49, 2007, Pages 8206-8208

  Berrington, Janet E ^a   Fenton, Alan C ^a   Cant, Andrew J ^b   Spickett, Gavin P ^a   O'Keeffe, Marilyn ^c   Matthews, John N S ^c  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Haemophilus influenzae type b; Inactivated polio vaccine; Preterm infant

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; INACTIVATED VACCINE; ORAL POLIOMYELITIS VACCINE; PEDIACEL; POLIOMYELITIS VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE; RIBITOL; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ARTICLE; DEMOGRAPHY; DRUG EFFICACY; ENZYME IMMUNOASSAY; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; POLIOMYELITIS; PREMATURITY; PRIORITY JOURNAL; UNITED KINGDOM;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; GREAT BRITAIN; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; POLYSACCHARIDES; TETANUS TOXOID; VACCINES, COMBINED;

EID: 36049043420     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.060     Document Type: Article

References (7)

1. Daum R.S., Zenko C., Given G., Ballanco G., Parikh H., and Germino K. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered. J Infect Dis 184 (2001) 1293-1299
2. Ramsay M., Begg N.T., Gandhi J., and Brown D. Antibody response and viral excretion after live polio vaccine or a combined schedule of live and inactivated polio vaccines. Pediatr Infect Dis J 13 (1994) 1117-1121
3. Daum R.S., Zenko C., Given G., Ballanco G., Parikh H., and Germino K. Absence of a significant interaction between a Haemophilus influenzae conjugate vaccine combined with a diphtheria toxoid, tetanus toxoid, and acellular pertussis vaccine in the same syringe and inactivated polio vaccine. Pediatr Infect Dis J 19 (2000) 710-717
4. Rennels M.B., Englund J., Bernstein D., Losonsky G.A., Anderson E., Pichichero M.E., et al. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination. Pediatr Infect Dis J 19 (2000) 417-423
5. Gold R., Scheifele D., Barreto L., Wiltsey S., Bjornson G., Meekison W., et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J 13 5 (1994) 348-355
6. Berrington J.E., Cant A.J., Matthews J.N.S., O'Keeffe M., Spickett G.P., and Fenton A.C. Hib immunisation in United Kingdom infants: effects of DTPaHib, significant prematurity and a fourth dose. Pediatrics 117 4 (2006) e1-e8
7. Stata Corporation. Stata Statistical Software: Release 7.0 (2001), Stata Corporation, College Station, TX